Clinical Trial Update: Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)

View source ↗

Summary

A Cleveland Clinic-sponsored trial evaluating the aldosterone-renin ratio (ARR) test for increasing detection of primary aldosteronism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Snippet

Sponsor: The Cleveland Clinic | Conditions: Primary Aldosteronism | Status: COMPLETED